Literature DB >> 33482899

Proinflammatory T cell polarization is already present in patients with early knee osteoarthritis.

Nils Rosshirt1, Richard Trauth2, Hadrian Platzer2, Elena Tripel2, Timo A Nees2, Hanns-Martin Lorenz3, Theresa Tretter3, Babak Moradi4.   

Abstract

BACKGROUND: Investigating the pathophysiological mechanisms of early osteoarthritis (OA) is of utmost interest since this stage holds the strongest promise for therapeutic interventions. The aims of this study were to analyze if synovial inflammation is already present in early OA and to characterize the involved cell populations, by investigating synovial fluid (SF) and synovial membrane (SM) of early OA patients for the presence and polarization status of CD4 T cells.
METHODS: A quantitative analysis of CD4+ T cell infiltration in SF and SM compared to peripheral blood (PB) was performed in patients with early stages of OA. We further investigated intracellular staining (ICS), surface marker, and chemokine receptor expression profiles of CD4+ T cells in SF, SM, and PB, as well as cytokine expression in native SF and PB. Matched samples of SF, SM, and PB were harvested from 40 patients with early OA at the time of surgery. Early OA was confirmed by independent surgeons intraoperatively. Samples were analyzed by flow cytometry for surface markers and cytokines, which are preferentially expressed by distinct T cell subsets (Th1, Th2, Th17, regulatory T cells). Furthermore, we analyzed native SF and PB supernatants using MACSPlex for multiple cytokine expression profiles.
RESULTS: SF and SM showed a distinct infiltration of CD4+ T lymphocytes, with significantly increased expression of chemokine receptors CXCR3/CCR5, cytokine IFN-γ (preferentially expressed by Th1 cells), and CD161 (preferentially expressed by IL-17 producing Th17 cells) compared to PB. Furthermore, the percentage of CD4+ T cells polarized to Treg was significantly increased in SM compared to SF and PB. No significant differences were observed for CCR3 and CCR4 (preferentially expressed by Th2 cells), although IL-4 values were significantly higher in SM and SF compared to PB. Cytokine analysis showed comparable results between PB and SF, with only IL-6 being significantly increased in SF.
CONCLUSIONS: Early OA joints show already significant inflammation through CD4+ T cell infiltration, with predominant Th1 cell polarization. Inflammation seems to be driven by direct proinflammatory cell interaction. Cytokine signaling seems to be negligible at the site of inflammation in early OA, with only IL-6 being significantly increased in SF compared to PB.

Entities:  

Keywords:  Chemokine receptor; Cytokines; Early OA; Inflammatory T cells; Synovial fluid; Synovial membrane; T cell polarization; T helper cells

Mesh:

Year:  2021        PMID: 33482899      PMCID: PMC7821658          DOI: 10.1186/s13075-020-02410-w

Source DB:  PubMed          Journal:  Arthritis Res Ther        ISSN: 1478-6354            Impact factor:   5.156


  55 in total

1.  Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms.

Authors:  Carla R Scanzello; Brian McKeon; Bryan H Swaim; Edward DiCarlo; Eva U Asomugha; Veero Kanda; Anjali Nair; David M Lee; John C Richmond; Jeffrey N Katz; Mary K Crow; Steven R Goldring
Journal:  Arthritis Rheum       Date:  2011-02

2.  The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK.

Authors:  W E Van Spil; P M J Welsing; S M A Bierma-Zeinstra; J W J Bijlsma; L D Roorda; H A Cats; F P J G Lafeber
Journal:  Osteoarthritis Cartilage       Date:  2015-03-26       Impact factor: 6.576

3.  Coexpression of chemokine receptors CCR5, CXCR3, and CCR4 and ligands for P- and E-selectin on T lymphocytes of patients with juvenile idiopathic arthritis.

Authors:  Andrew C Issekutz; Patrick J Quinn; Bianca Lang; Suzanne Ramsey; Adam M Huber; Derek Rowter; Mohan Karkada; Thomas B Issekutz
Journal:  Arthritis Rheum       Date:  2011-11

4.  Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes.

Authors:  Abdul Haseeb; Mohammad Yunus Ansari; Tariq M Haqqi
Journal:  J Orthop Res       Date:  2016-05-04       Impact factor: 3.494

5.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.

Authors:  R Altman; E Asch; D Bloch; G Bole; D Borenstein; K Brandt; W Christy; T D Cooke; R Greenwald; M Hochberg
Journal:  Arthritis Rheum       Date:  1986-08

Review 6.  Inflammation in osteoarthritis.

Authors:  Mary B Goldring; Miguel Otero
Journal:  Curr Opin Rheumatol       Date:  2011-09       Impact factor: 5.006

7.  Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis.

Authors:  L R Wedderburn; N Robinson; A Patel; H Varsani; P Woo
Journal:  Arthritis Rheum       Date:  2000-04

8.  Very early osteoarthritis changes sensitively fluid flow properties of articular cartilage.

Authors:  J T A Mäkelä; S-K Han; W Herzog; R K Korhonen
Journal:  J Biomech       Date:  2015-06-27       Impact factor: 2.712

9.  Expression of MDC/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.

Authors:  Helene Aarslev Flytlie; Malene Hvid; Esther Lindgreen; Emil Kofod-Olsen; Eva Lykke Petersen; Anette Jørgensen; Mette Deleuran; Christian Vestergaard; Bent Deleuran
Journal:  Cytokine       Date:  2009-11-25       Impact factor: 3.861

10.  Impact of Mononuclear Cell Infiltration on Chondrodestructive MMP/ADAMTS Production in Osteoarthritic Knee Joints-An Ex Vivo Study.

Authors:  Hadrian Platzer; Timo A Nees; Tobias Reiner; Elena Tripel; Simone Gantz; Sébastien Hagmann; Babak Moradi; Nils Rosshirt
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

View more
  7 in total

1.  Identification of Biomarkers Associated with Diagnosis of Osteoarthritis Patients Based on Bioinformatics and Machine Learning.

Authors:  Yihao Liang; Fangzheng Lin; Yunfei Huang
Journal:  J Immunol Res       Date:  2022-06-13       Impact factor: 4.493

Review 2.  Synovial inflammation in osteoarthritis progression.

Authors:  Elsa Sanchez-Lopez; Roxana Coras; Alyssa Torres; Nancy E Lane; Monica Guma
Journal:  Nat Rev Rheumatol       Date:  2022-02-14       Impact factor: 32.286

Review 3.  Osteoarthritis Pathophysiology: Therapeutic Target Discovery may Require a Multifaceted Approach.

Authors:  Tonia L Vincent; Tamara Alliston; Mohit Kapoor; Richard F Loeser; Linda Troeberg; Christopher B Little
Journal:  Clin Geriatr Med       Date:  2022-05       Impact factor: 3.529

Review 4.  The Genesis of Pain in Osteoarthritis: Inflammation as a Mediator of Osteoarthritis Pain.

Authors:  Matthew J Wood; Rachel E Miller; Anne-Marie Malfait
Journal:  Clin Geriatr Med       Date:  2022-05       Impact factor: 3.529

5.  CD8+ T Cells in OA Knee Joints Are Differentiated into Subsets Depending on OA Stage and Compartment.

Authors:  Hadrian Platzer; Richard Trauth; Timo A Nees; Elena Tripel; Simone Gantz; Marcus Schiltenwolf; Babak Moradi; Nils Rosshirt
Journal:  J Clin Med       Date:  2022-05-17       Impact factor: 4.964

6.  Unraveling the Signaling Secretome of Platelet-Rich Plasma: Towards a Better Understanding of Its Therapeutic Potential in Knee Osteoarthritis.

Authors:  Cristina Del Amo; Arantza Perez-Valle; Leire Atilano; Isabel Andia
Journal:  J Clin Med       Date:  2022-01-18       Impact factor: 4.241

7.  In Vitro Anti-Inflammatory and Regenerative Effects of Autologous Conditioned Serum from Dogs with Osteoarthritis.

Authors:  Sirikul Soontararak; Piyathida Ardaum; Napaporn Senarat; Sarawut Yangtara; Chalermpol Lekchareonsuk; Iyarath Putchong; Narudee Kashemsant; Monchanok Vijarnsorn; Lyndah Chow; Steven Dow; Porntippa Lekchareonsuk
Journal:  Animals (Basel)       Date:  2022-10-10       Impact factor: 3.231

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.